Opportunity Overview
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s).
Distinctive Features:
• Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity.
• Studies utilizing animal models do not meet the intent of the mechanism and are not allowed.
• Preliminary data are required.
• Community collaboration is required for research prospectively enrolling human subjects.
• The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.
• Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Distinctive Features:
• Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity.
• Studies utilizing animal models do not meet the intent of the mechanism and are not allowed.
• Preliminary data are required.
• Community collaboration is required for research prospectively enrolling human subjects.
• The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.
• Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Defense Health Agency Contracting Activity - DHACA |
|---|---|
| Country | United States |
| Category | Defense Security |
| Published | May 01, 2026 |
| Procurement stage | Active solicitation |
| Closed | September 24, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 11, 2026 |
Source: U.S. Government (Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
Browse Similar Open Opportunities in United States
See every United States Defense Security opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Defense Security intelligence report in your inbox
A personalized report on United States Defense Security opportunities, emailed in 5-10 minutes. One per month, no account needed.